loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 204057 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Glenmark Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 GLENMARK PHARMS (1)

    filter

    01 TABLET;ORAL-28 (1)

    filter

    01 RX (1)

    filter

    01 NORGESTIMATE AND ETHINYL ESTRADIOL (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ETHINYL ESTRADIOL; NORGESTIMATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL-28
    0.025MG,0.025MG,0....
    2016-02-23
    204057
    NORGESTIMATE AND E...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 204057

    Looking for FDA Orange Book APPLICATION 204057 1

    19

    Glenmark Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is ETHINYL ESTRADIOL; NORGESTIMATE, with a corresponding application number 204057.

    Regulatory Information RX

    With a dosage strength 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG

    Dosage Form Route TABLET; ORAL-28

    Reference Listed Drug No

    Approved since 2016-02-23

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY